Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

Q: What does CUSIP 03168L105 represent in this 13F holders report?

CUSIP 03168L105 is the security identifier for AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 used to aggregate holder disclosures.

Q: How many institutions held AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in Q2 2020?

131 institutional investors reported AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 03168L105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Class A Common Stock, par value $0.01
Shares outstanding: 313,041,907
Total 13F shares: 101,691,059
Share change: +3,242,253
Total reported value: $484,034,077
Put/Call ratio: 52%
Price per share: $4.76
Number of holders: 131
Value change: +$16,566,905
Number of buys: 62
Number of sells: 68

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 03168L105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Fosun International Ltd	13F	Company	6.9%	21,521,301	$74,893,000	—	31 Mar 2020	13F
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	5.2%	16,213,367	$56,423,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	4.9%	15,323,849	$53,325,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	3.4%	10,741,404	$37,381,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	3%	9,299,973	$32,363,000	—	31 Mar 2020	13F
Neuberger Berman Group LLC	13F	Company	1.2%	3,830,086	$13,303,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	0.77%	2,417,142	$8,412,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.55%	1,706,562	$5,938,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.5%	1,554,407	$5,409,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.47%	1,464,659	$5,097,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.4%	1,253,008	$4,360,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.36%	1,127,504	$3,924,000	—	31 Mar 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.31%	976,119	$3,397,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.23%	706,806	$2,460,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.17%	543,569	$1,891,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.16%	515,787	$1,795,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.16%	500,280	$1,741,000	—	31 Mar 2020	13F
LSV ASSET MANAGEMENT	13F	Company	0.11%	355,800	$1,238,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.11%	351,576	$1,224,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.1%	310,149	$1,079,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.09%	268,505	$935,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	268,260	$934,000	—	31 Mar 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.08%	247,774	$862,000	—	31 Mar 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.08%	236,760	$824,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	0.07%	229,724	$800,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	219,728	$765,000	—	31 Mar 2020	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	216,842	$755,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	214,326	$746,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.07%	213,549	$743,000	—	31 Mar 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.07%	208,396	$724,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.07%	208,100	$724,000	—	31 Mar 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	0.07%	205,485	$715,000	—	31 Mar 2020	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.06%	199,263	$693,000	—	31 Mar 2020	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.06%	190,184	$662,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	182,500	$635,000	—	31 Mar 2020	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.06%	182,291	$634,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.06%	179,688	$625,000	—	31 Mar 2020	13F
MACKENZIE FINANCIAL CORP	13F	Company	0.06%	177,878	$619,000	—	31 Mar 2020	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.05%	167,514	$583,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	155,006	$539,000	—	31 Mar 2020	13F
Spark Investment Management LLC	13F	Company	0.04%	136,658	$475,000	—	31 Mar 2020	13F
STRS OHIO	13F	Company	0.04%	136,500	$475,000	—	31 Mar 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.04%	131,860	$459,000	—	31 Mar 2020	13F
Engineers Gate Manager LP	13F	Company	0.04%	127,564	$444,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.04%	123,976	$431,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.04%	118,340	$413,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.04%	116,728	$406,213	—	31 Mar 2020	13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC	13F	Company	0.04%	111,896	$390,000	—	31 Mar 2020	13F
SYSTEMATIC FINANCIAL MANAGEMENT LP	13F	Company	0.04%	110,580	$385,000	—	31 Mar 2020	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.03%	106,783	$372,000	—	31 Mar 2020	13F

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2020

As of 30 Jun 2020, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 101,691,059 shares. The largest 10 holders included Fosun International Ltd, TPG Group Holdings (SBS) Advisors, Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Neuberger Berman Group LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP. This page lists 131 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

117

Q2 2020 holders

131

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.